What type of study is this?

This is a Experimental Study study.

October 23, 2025Open Access

Future innovative radionuclides for cancer treatment at INFN

Key Points

Research highlights the potential of radionuclides in improving cancer treatment outcomes, leading to more effective therapies.
Key findings indicate promising developments in particle physics that can enhance cancer treatment strategies.
Assessment involved the use of innovative technologies and particle accelerators at the Legnaro National Laboratories to explore new treatment options.
This initiative may enable significant improvements in cancer therapies, addressing the urgent need for effective treatment.

Abstract

Future innovative radionuclides for cancer treatment at INFN The Italian Institute for Nuclear Physics conducts cutting-edge research in the field of nuclear, particle, and astroparticle physics, as well as in developing technologies for research and their applications to benefit society. Founded in 1951, the Italian Institute for Nuclear Physics (INFN) is the public research institute that has taken up the scientific legacy of Enrico Fermi for more than seventy years. Among the four INFN National Laboratories, the Legnaro National Laboratories (LNL, Legnaro, Padova) are internationally recognised for conducting state-of-the-art research in the field of nuclear physics and its applications, thanks to the five particle accelerators and related technologies available there.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Gaia Pupillo (Mon,) studied this question.

synapsesocial.com/papers/68f9a0eb8ea8f2f37ee94a86 https://doi.org/https://doi.org/10.56367/oag-048-12344

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper